Clinical Trial Update: A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial results show safety and effectiveness of infliximab for treatment of psoriatic arthritis; the study is complete.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Arthritis, Psoriatic | Phase 3 | Status: COMPLETED